- Home
- MBRX vs GENK Comparison
MBRX vs GENK Comparison
Compare MBRX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBRX | GENK |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | N/A | 2700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1M | 12.8M |
| IPO Year | 2016 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MBRX | GENK |
|---|---|---|
| Price | $2.38 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $61.00 | $4.50 |
| AVG Volume (30 Days) | ★ 258.5K | 20.2K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | N/A | ★ 62.50 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $208,380,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | $7.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.12 |
| 52 Week Low | $0.25 | $1.43 |
| 52 Week High | $7.98 | $4.98 |
Technical Indicators
Market Signals| Indicator | MBRX | GENK |
|---|---|---|
| Relative Strength Index (RSI) | 47.06 | 50.23 |
| Support Level | $2.16 | $1.53 |
| Resistance Level | $2.64 | $2.51 |
| Average True Range (ATR) | 0.20 | 0.16 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 19.40 | 41.91 |
Price Performance
Historical ComparisonAbout MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. The group operates its restaurants in California, Arizona, Hawaii, Nevada, Texas, New York, Oregon, North Carolina, Washington, New Jersey, Florida and South Korea.